Global Travel Vaccines Market Size and Forecast to 2029: Revenue, Growth, and Trends

Uncover key drivers, emerging technologies, and competitive movements shaping the travel vaccines market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The Travel Vaccines Market Size Today And What Will Its Value Be At The End Of 2029?

The microbial API market size has seen robust growth in recent years. It is anticipated to expand from $62.9 billion in 2024 to $67.52 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.4%. The expansion observed historically is due to factors such as increased demand for medications, a greater governmental focus on healthcare and pharmaceuticals, a heightened need to satisfy nutritional requirements, considerations of sustainability and cost-efficiency, and a surge in the demand for biological drugs.

The microbial API market is projected to experience robust expansion over the coming years. Its value is anticipated to reach $89.86 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.4%. This projected growth during the forecast period is primarily driven by factors such as increasing applications in the pharmaceutical industry, the rising prevalence of chronic conditions, escalating healthcare expenditure, improved access to advanced medical infrastructure, and a rise in infections and antibiotic resistance. Major trends influencing the market in this period include advancements in fermentation and downstream processing technologies, innovations in microbial fermentation technologies, heightened investments in bioprocessing, breakthroughs in molecular biology and synthetic biology, and continuous product innovation.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15861&type=smp

Which Key Drivers Are Powering Growth In The Travel Vaccines Market?

The escalating occurrence of chronic conditions is anticipated to fuel the expansion of the microbial API market in the future. A chronic condition refers to a long-term health issue or illness characterized by its persistent or extended effects. The increase in chronic conditions stems from various elements, such as an aging populace, inactive lifestyles, inadequate nutrition, shifts in the environment, and enhanced disease detection and diagnosis. Microbial APIs are increasingly utilized in addressing chronic conditions, harnessing their medicinal attributes originating from microorganisms to formulate potent therapies. For example, in February 2024, the World Health Organization, an intergovernmental body based in Switzerland, forecast over 35 million new cancer cases by 2050, signifying a 77% rise from the approximately 20 million cases estimated in 2022. Consequently, the growing prevalence of chronic conditions is a key factor driving the demand within the microbial API market.

Which Segment Categories Are Driving Maximum Growth In The Travel Vaccines Market?

The microbial api market covered in this report is segmented –

1) By Type: Antibody, Peptide, Protein, Small Molecule, Vaccine

2) By Host: Mammalian, Bacterial, Fungal

3) By Site: In-House, Outsourced

4) By Molecule: Innovative, Generic

5) By End-Use: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses

Subsegments:

1) By Antibody: Monoclonal Antibodies, Polyclonal Antibodies

2) By Peptide: Therapeutic Peptides, Diagnostic Peptides

3) By Protein: Recombinant Proteins, Native Proteins

4) By Small Molecule: Antibiotics, Antifungals, Antivirals

5) By Vaccine: Bacterial Vaccines, Viral Vaccines

What Key Trends Are Driving Growth In The Travel Vaccines Market?

Major companies in the microbial API market are developing innovative API products, such as excipients, to improve drug effectiveness, enhance formulation stability, and meet regulatory requirements. Excipients are substances formulated alongside the active ingredient of medication to fulfill various purposes, including stabilization, bulking up formulations, enhancing therapeutic properties, and assisting in manufacturing. For instance, in October 2023, Clariant, a Switzerland-based chemical company, introduced a new range of excipients to boost the stability and solubility of active pharmaceutical ingredients (APIs). This expansion features three new VitiPure excipients designed to address challenges in API delivery and bioavailability, suitable for different dosage applications such as oral, topical, and parenteral administration. These excipients aim to support the pharmaceutical industry by providing effective carrier systems for drug delivery, particularly for sensitive medications like mRNA vaccines and biologics.

Who Are The Leading Companies Driving The Travel Vaccines Market?

Major companies operating in the microbial API market are BASF SE, Merck& Co Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc, GlaxoSmithKline Plc, Eli Lilly And Company, Boehringer Ingelheim GmbH, Amgen Inc., Evonik Industries AG, TEVA Pharmaceutical industries Ltd., Lonza Group AG, Catalent Inc., CSPC Pharmaceutical Group Ltd., Patheon, Dr. Reddy’s Laboratories Ltd., Siegfried Ltd., Recipharm AB, Shandong Lukang Pharmaceutical Co. Ltd., Tianjin Tianyao Pharmaceuticals Co. Ltd., Xellia Pharmaceuticals, Kolon Life Science Inc., Royal DSM NV, Henan Topfond Pharmaceutical Co. Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/microbial-api-global-market-report

Which Region Holds The Largest Share In The Travel Vaccines Market Today?

Asia-Pacific was the largest region in the microbial API market in 2024. The regions covered in the microbial API market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15861&type=smp

Browse Through More Reports Similar to the Global Travel Vaccines Market 2025, By The Business Research Company

Antimicrobial Medical Device Coatings Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antimicrobial-medical-device-coatings-global-market-report

Antimicrobial Plastics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antimicrobial-plastics-global-market-report

Antimicrobial Susceptibility Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antimicrobial-susceptibility-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795